Targeting cardiovascular risk in renal transplantation.
Kiberd
B A
BA
Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
West
K A
KA
D002318:Cardiovascular Diseases / Q000191:economics / Q000401:mortality / Q000517:prevention & control*; D017281:Cost of Illness; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000191:economics / Q000401:mortality*; D008954:Models, Biological; D012307:Risk Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine